{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.146","meta":{"versionId":"6","lastUpdated":"2021-03-06T01:00:18.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.146","version":"20210306","name":"Aprepitant Injectable","status":"active","date":"2021-03-06T01:00:18-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1995150","display":"18 ML aprepitant 7.2 MG/ML Injection"}]}]},"expansion":{"identifier":"urn:uuid:ffe9feaf-83c2-4d15-9dd6-7cd37b151b6c","timestamp":"2022-06-10T04:45:58-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1995150","display":"18 ML aprepitant 7.2 MG/ML Injection"}]}}